Skip to Content

Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated

The future for patients with mantle cell lymphoma is to be treated with novel targeted drugs upfront and also immunotherapy. This also includes elderly patients, who have a much worse prognosis, says professor Ingrid Glimelius, Uppsala University, in this MEDtalk from EHA 2024.

Ingrid Glimelius

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top